Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Dr. Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Boyoung Park | Epidemiology | Best Researcher Award

Prof. Boyoung Park | Epidemiology | Best Researcher Award

Prof. Boyoung Park, Hanyang University College of Medicine, South Korea

Professor Boyoung Park is a distinguished expert in preventive medicine, currently serving at Hanyang University College of Medicine in Seoul, South Korea. She leads the Bio-Big Data Center at the Hanyang Institute of Bioscience and Biotechnology. Her research, focusing on breast cancer risk factors and epidemiology, has been published in reputable journals such as the British Journal of Cancer and BMJ Open. In 2023, she was honored with the Kwangdong Cancer Academic Award by the Korean Cancer Association. Additionally, she contributes to the academic community as a senior editor for the Journal of Preventive Medicine & Public Health.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Professor Boyoung Park embarked on her medical education at the Catholic University of Daegu, where she earned her M.D. in 2006. Her passion for preventive medicine led her to Seoul National University College of Medicine, where she obtained her M.S. in 2010 and subsequently completed her Ph.D. in 2012. This strong academic foundation set the stage for her future contributions to epidemiology and cancer research.

💼 PROFESSIONAL ENDEAVORS:

Prof. Park’s career trajectory has been marked by prestigious positions in both academia and research institutions:

  • Director of the Bio-BigData Center at the Hanyang Institute of Bioscience and Biotechnology (2024–present)
  • Professor at the Department of Preventive Medicine, Hanyang University College of Medicine (2023–present)
  • Associate Professor at Hanyang University College of Medicine (2018–2023)
  • Assistant Professor at the National Cancer Center Graduate School of Cancer Science and Policy (2015–2018)
  • Associate Scientist at the National Cancer Control Institute, National Cancer Center (2012–2018)
  • Fellowship at the National Cancer Control Institute, National Cancer Center (2011–2012)
  • Residency in Preventive Medicine at Seoul National University College of Medicine (2008–2011)
  • Internship at Asan Medical Center, Seoul (2006–2007)

Her experience spans clinical practice, research, and academic leadership, demonstrating her commitment to advancing public health and epidemiology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY:

Prof. Park has played a crucial role in cancer epidemiology, HIV research, and the development of disease risk assessment models. Her research interests include:

  • Cancer prevention and control
  • HIV/AIDS and chronic infectious diseases
  • Big data and epidemiological studies
  • Genome analysis and risk assessment models

🏆 RESEARCH GRANTS:

She has led multiple nationally funded projects, including:

  • Korea HIV/AIDS Cohort Study (2023–2024) – Principal Investigator
  • Korea Atomic Bomb Survivors Cohort and Genome Analysis (2020–2024) – Principal Investigator
  • Development of a Breast Cancer Risk Assessment Model (2021–2025) – Principal Investigator
  • Transfusion and Prognosis in Hepatobiliary & Pancreatic Surgery (2022–2025) – Principal Investigator

🏅 IMPACT AND INFLUENCE:

Prof. Park’s work has been widely recognized through prestigious awards and honors, such as:

  • National AIDS and STI Contributor Award (2023) – Korea Disease Control and Prevention Agency
  • Kwangdong Cancer Academic Award (2023) – Korean Cancer Association
  • Outstanding Paper Review Committee Award (2022) – Korean Society of Epidemiology
  • Excellent Researcher Award (2021) – Hanyang University
  • Young Epidemiologist Award (2015) – Korean Society of Epidemiology

📖 ACADEMIC CITATIONS AND EDITORIAL CONTRIBUTIONS:

Prof. Park serves as a Senior Editor and Editorial Board Member for leading medical journals:

  • Journal of Preventive Medicine & Public Health (Senior Editor)
  • Cancer Research and Treatment (Editorial Board Member)
  • Journal of Cancer Prevention (Editorial Board Member)

Her contributions to medical literature have significantly shaped the fields of epidemiology and public health.

🔮 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Boyoung Park has established herself as a leading figure in preventive medicine and cancer epidemiology. Moving forward, she aims to:
 Advance big data-driven epidemiological research
Enhance public health policies for cancer prevention
Develop personalized risk assessment models for chronic diseases
Strengthen national and global health collaborations

Her groundbreaking work continues to shape the future of epidemiology, public health, and medical research in South Korea and beyond.

🌍CONCLUSION:

Professor Boyoung Park has made significant contributions to preventive medicine, epidemiology, and cancer research. As the Director of the Bio-Big Data Center at Hanyang University, her work in breast cancer risk assessment and public health continues to shape medical advancements. Recognized with prestigious awards, including the Kwangdong Cancer Academic Award, she remains a leading figure in medical research. Through her editorial roles and government advisory positions, she influences healthcare policies and scientific discourse. Her legacy will inspire future researchers and improve global public health outcomes.

TOP NOTABLE PUBLICATIONS

Economic Evaluation of Mass Screening as a Strategy for Hepatitis C Virus Elimination in South Korea

Authors: Hwa-young Choi, Kyung-ah Kim, Boyoung Park, Bo-youl Choi, Moran Ki

Journal: Journal of Infection and Public Health

Year: 2025

Korean Patients with Hereditary Cancer: A Prospective Multicentre Cohort Study Protocol Exploring Psychosocial and Health Outcomes

Authors: Jun-kyu Kim, Mi-Ae Jang, Jong-eun Park, Boyoung Park, Sun-young Kong

Journal: BMJ Open

Year: 2025

Associations Between Breastfeeding and Breast Cancer Risk Through Mammographic Breast Density in a Cohort of Korean Women

Authors: Soyeoun Kim, Thi Xuan Mai Tran, Mi-kyung Kim, Woojoo Lee, Boyoung Park

Journal: International Journal of Epidemiology

Year: 2025

Concordant and Discordant Breast Density Patterns by Different Approaches for Assessing Breast Density and Breast Cancer Risk

Authors: Yoosun Cho, Eunkyung Park, Yoosoo Chang, Shinho Kook, Seungho Ryu

Journal: Breast Cancer Research and Treatment

Year: 2025

A National Estimate of Mental Disorders and Mortality Outcomes in Cancer Survivors

Authors: Thi Xuan Mai Tran, Minsung Chung, Boyoung Park

Journal: Cancer

Year: 2025

Refining Breast Cancer Genetic Risk and Biology Through Multi-Ancestry Fine-Mapping Analyses of 192 Risk Regions

Authors: Guochong Jia, Zhishan Chen, Jie Ping, Jirong Long, Wei Zheng

Journal: Nature Genetics

Year: 2025

Carrier Frequency and Incidence of MUTYH-Associated Polyposis Based on Database Analysis in East Asians and Koreans

Authors: Jong-eun Park, Taeheon Lee, Eun-hye Cho, Chang-Seok Ki, Sun-young Kong

Journal: Annals of Laboratory Medicine

Year: 2025

Correction to: Height and Breast Cancer Risk in Premenopausal Korean Women Aged Under 40 Years of Age

Authors: Thi Xuan Mai Tran, Yoosoo Chang, Hye-rin Choi, Seungho Ryu, Boyoung Park

Journal: British Journal of Cancer

Year: 2024

Height and Breast Cancer Risk in Premenopausal Korean Women Aged Under 40 Years of Age: Epidemiology

Authors: Thi Xuan Mai Tran, Yoosoo Chang, Hye-rin Choi, Seungho Ryu, Boyoung Park

Journal: British Journal of Cancer

Year: 2024

Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study

Authors: Yunsu Choi, Kyoung-hwan Ahn, Soomin Kim, Yoonhee Jun, Boyoung Park

Journal: Infection and Chemotherapy

Year: 2024

Paweł Rajewski | Cardiovascular risk | Best Research Article Award | Best Research Article Award

🏥Current Position and Roles:

Dr. Paweł Rajewski is a distinguished medical doctor, professor, and the rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz. He holds the vital role of Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship, providing oversight and strategic insights on infectious disease management in the region. Dr. Rajewski serves as the Head of the Department of Internal Medicine and Infectious Diseases at the Tadeusz Browicz Provincial Infectious Disease Hospital in Bydgoszcz, as well as the Head of the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Previously, he served as the Medical Director and Head of the Department of Internal Medicine and Hepatology at the Emil Warmiński Multispecialist City Hospital. Through these roles, he contributes to the health of countless patients while also shaping medical policy and practice.

🎓Academic Background:

Dr. Rajewski’s academic journey has been marked by an enduring commitment to medicine, specializing in areas such as internal medicine, infectious diseases, hepatology, and clinical transplantation. His qualifications in these areas form the bedrock of his clinical and academic expertise, enabling him to deliver high-impact research and patient care in fields that are central to public health. Dr. Rajewski’s education includes specialty certifications as a lipidologist, accredited by the Polish Lipid Association, and an obesitologist with certifications from the Polish Association for the Study of Obesity and the Polish Society for Obesity Treatment.

📚Research Interests and Publication Achievements: 

Dr. Rajewski has contributed over 200 articles, primarily focused on metabolic disorders, obesity, liver diseases, and cardiovascular risk factors. His work, published in reputed medical journals, has been instrumental in advancing knowledge on these critical health issues. His research sheds light on complex metabolic processes, influencing both preventive and therapeutic approaches to conditions like non-alcoholic fatty liver disease and atherosclerosis. His publications are widely recognized for their scientific rigor and relevance, contributing to his esteemed reputation in the medical research community.

🔬Ongoing Research Projects:

Dr. Rajewski is currently engaged in various research projects that address emerging concerns in metabolic health and infectious diseases. His work on liver disease mechanisms and cardiovascular risk factors associated with obesity and metabolic syndrome aims to uncover better diagnostic markers and treatment pathways. A recent focus involves studying COVID-19’s impact on liver function and the interplay between viral infections and metabolic health, topics highly relevant in today’s healthcare landscape.

👥Professional Associations and Certifications: 

Dr. Rajewski’s memberships in prestigious medical associations, including the Polish Lipid Association and the Polish Association for the Study of Obesity, underscore his dedication to staying at the forefront of medical science. His certified expertise as a lipidologist and obesitologist enables him to approach health issues with a comprehensive understanding of lipid and metabolic disorders, enhancing the efficacy of treatments and preventive measures.

🏆Scholarships and Awards: 

Dr. Rajewski’s contributions to medicine have earned him numerous accolades, recognizing his achievements in research and clinical practice. These awards celebrate his innovation in metabolic research and his pivotal role in infectious disease management. His scholarship funding reflects a legacy of excellence and a commitment to advancing medical science.

📖Training & Workshops Attended:

In his pursuit of continual growth, Dr. Rajewski has attended a series of specialized workshops on bioinformatics, advanced diagnostics, and clinical applications in infectious disease management. These workshops equip him with cutting-edge skills that he applies to his daily work, benefiting patients and enhancing the training of his medical students.

💻Contributions to Bioinformatics and Clinical Research: 

A proficient bioinformatician, Dr. Rajewski integrates data science and computational tools in his research on metabolic diseases and infectious pathogens. By utilizing bioinformatics, he has been able to analyze complex datasets, leading to insights into genetic predispositions and disease progression. His ability to harness bioinformatics tools strengthens his work in both metabolic and infectious disease studies, positioning him at the cutting edge of medical research.

🎤Oral Presentations and Conferences: 

As a frequent presenter at national and international conferences, Dr. Rajewski shares his research findings with the medical community. His presentations cover topics like liver disease pathogenesis, metabolic syndrome treatments, and emerging infectious diseases. He contributes actively to knowledge exchange, with his lectures serving as valuable learning resources for both peers and students.

📊Key Tasks and Responsibilities as a Researcher:

In his research role, Dr. Rajewski coordinates multi-disciplinary teams, designing studies, and conducting extensive data analyses. His responsibilities include overseeing clinical trials and ensuring the ethical integrity of research protocols. His dedication to stringent research standards has led to significant findings that improve patient care protocols and inform public health strategies.

🌠Success Factors:

Dr. Rajewski attributes his success to his commitment to continuous learning, innovation, and collaboration. His ability to bridge theoretical research with practical applications in healthcare makes his contributions exceptionally valuable. Additionally, his leadership in the clinical setting exemplifies his holistic approach to healthcare, balancing research with direct patient care.

🔍Publications & Laboratory Experience:

Dr. Rajewski’s extensive laboratory experience includes advanced diagnostics in liver diseases, where he employs innovative techniques to diagnose and manage conditions like hepatitis and liver fibrosis. His publications detail his findings on the effectiveness of new biomarkers, offering insights that enhance both diagnostics and treatment options for liver and metabolic disorders.

🌐Conclusion: 

Dr. Paweł Rajewski’s career exemplifies a dedication to excellence in medicine, research, and public health. His multifaceted expertise in internal medicine, infectious diseases, and metabolic health has propelled him to the forefront of healthcare in Poland. Dr. Rajewski’s contributions are invaluable to the fields of hepatology and infectious disease, positively impacting patient care and advancing medical knowledge. Through his foundation, research, and clinical roles, he continues to shape the future of health sciences, creating a lasting legacy of compassion, knowledge, and innovation.

 

Top Notable Publications:

 

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults

Authors: Not listed; need to check for full author details.

Year: 2024

Citation: Biomedicines, 2024, 12(10), article 2400. DOI: 10.3390/biomedicines12102400.

Feasibility and Cardiometabolic Effects of Time-Restricted Eating in Patients with Metabolic Syndrome

Authors: Not listed; need to check for full author details.

Year: 2024

Citation: Nutrients, 2024, 16(12), article 1802. DOI: 10.3390/nu16121802.

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Journal of Clinical Medicine, 2022, 11(17), article 5193. DOI: 10.3390/jcm11175193.

The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Vaccines, 2022, 10(4), article 506. DOI: 10.3390/vaccines10040506.

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Journal of Clinical Medicine, 2022, 11(2), article 379. DOI: 10.3390/jcm11020379.

Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Vaccines, 2022, 10(1), article 99. DOI: 10.3390/vaccines10010099.

Pilot Clinical Trial of Time-Restricted Eating in Patients with Metabolic Syndrome

Authors: Not listed; need to check for full author details.

Year: 2021

Citation: Nutrients, 2021, 13(2), article 346. DOI: 10.3390/nu13020346.

Resveratrol’s Impact on Vascular Smooth Muscle Cells Hyporeactivity: The Role of Rho-Kinase Inhibition

Authors: Not listed; need to check for full author details.

Year: 2020

Citation: BioMed Research International, 2020, article 9012071. DOI: 10.1155/2020/9012071.

Zakażenie wirusem cytomegalii w praktyce klinicznej – diagnostyka, objawy i leczenie w świetle aktualnej wiedzy

Authors: Not listed; need to check for full author details.

Year: 2019

Citation: Forum Zakażeń, 2019, issue 4, article FZ2019042. DOI: 10.15374/FZ2019042.

Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie‐Restricted Diet

Authors: Not listed; need to check for full author details.

Year: 2017

Citation: Oxidative Medicine and Cellular Longevity, 2017, article 8494107. DOI: 10.1155/2017/8494107.